# Phase I Study of Colistin Methanesulfonate Sodium

> **NCT01449838** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 22 (actual)

## Conditions studied

- Infections, Pseudomonas

## Interventions

- **DRUG:** Colistimethate sodium
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT01449838
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10-23
- **Primary completion:** 2010-12-09
- **Final completion:** 2010-12-09
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2017-07-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01449838

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01449838, "Phase I Study of Colistin Methanesulfonate Sodium". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01449838. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*